Surgery Partners, Inc.

Informe acción NasdaqGS:SGRY

Capitalización de mercado: US$3.2b

Surgery Partners Dirección

Dirección controles de criterios 3/4

El CEO de Surgery Partners' es J. Evans , nombrado en Jan 2020, tiene una permanencia de 4.25 años. compensación anual total es $6.09M, compuesta por 17.2% salario y 82.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.37% de las acciones de la empresa, por valor de $11.42M. La antigüedad media del equipo directivo y de la junta directiva es de 2.8 años y 6 años, respectivamente.

Información clave

J. Evans

Chief Executive Officer (CEO)

US$6.5m

Compensación total

Porcentaje del salario del CEO16.3%
Permanencia del CEO4.3yrs
Participación del CEO0.4%
Permanencia media de la dirección2.8yrs
Promedio de permanencia en la Junta Directiva6yrs

Actualizaciones recientes de la dirección

Recent updates

Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Apr 24
Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Mar 18
Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Feb 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Dec 19
The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Oct 26
Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Sep 17
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

Aug 26
Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Jul 21
The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

Jun 15
Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

May 26
A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Apr 14
There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Mar 24
Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jan 24
Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

Sep 26
We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Aug 15
The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Surgery Partners GAAP EPS of -$0.21 misses by $0.07, revenue of $615.4M misses by $3.61M

Aug 02

Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders

Jul 02

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Jun 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Mar 27
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Is Surgery Partners (NASDAQ:SGRY) A Risky Investment?

Dec 06
Is Surgery Partners (NASDAQ:SGRY) A Risky Investment?

Estimating The Fair Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

Oct 04
Estimating The Fair Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Aug 05
Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de J. Evans en comparación con los beneficios de Surgery Partners?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023US$6mUS$1m

-US$12m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

-US$54m

Mar 31 2023n/an/a

-US$92m

Dec 31 2022US$6mUS$1m

-US$55m

Sep 30 2022n/an/a

-US$31m

Jun 30 2022n/an/a

-US$29m

Mar 31 2022n/an/a

-US$38m

Dec 31 2021US$4mUS$1m

-US$81m

Sep 30 2021n/an/a

-US$86m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$150m

Dec 31 2020US$4mUS$916k

-US$156m

Sep 30 2020n/an/a

-US$179m

Jun 30 2020n/an/a

-US$132m

Mar 31 2020n/an/a

-US$119m

Dec 31 2019US$5mUS$435k

-US$110m

Compensación vs. Mercado: La compensación total ($USD6.09M) de J. está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD6.59M).

Compensación vs. Ingresos: La compensación de J. ha aumentado mientras la empresa no es rentable.


CEO

J. Evans (46 yo)

4.3yrs

Permanencia

US$6,457,600

Compensación

Mr. J. Eric Evans has been the Chief Executive Officer and Director of Surgery Partners, Inc. since January 13, 2020 and served as its Executive Vice President and Chief Operating Officer since April 1, 20...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Wayne DeVeydt
Executive Chairman6.3yrsUS$250.00k0.080%
$ 2.6m
J. Evans
CEO & Director4.3yrsUS$6.46m0.36%
$ 11.8m
David Doherty
Executive VP & CFO2.3yrsUS$3.52m0.076%
$ 2.5m
Jennifer Baldock
Executive VP and Chief Administrative & Development Officer4.3yrsUS$3.09m0.15%
$ 4.7m
Bradley Owens
President of National Group4.4yrsUS$1.61m0.062%
$ 2.0m
Marissa Brittenham
Executive VP & Chief Strategy Officer2.3yrsUS$1.68m0.031%
$ 1.0m
Neil Zieselman
Senior Vice President of Corporate Finance & Controller2yrssin datossin datos
Varun Gadhok
Senior VP & Chief Information Officer2.8yrssin datossin datos
Roxanne Womack
Senior VP & Chief Compliance Officer5.5yrssin datossin datos
Danielle Burkhalter
Executive VP & Chief Human Resources Officer1.3yrssin datos0.029%
$ 930.7k
Anthony Taparo
Chief Growth Officer4.8yrsUS$1.30m0.081%
$ 2.6m
Harrison Bane
President of American Group1.7yrsUS$2.43m0.042%
$ 1.4m

2.8yrs

Permanencia media

49yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de SGRY se considera experimentado (2.8 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Wayne DeVeydt
Executive Chairman6.3yrsUS$250.00k0.080%
$ 2.6m
J. Evans
CEO & Director4.3yrsUS$6.46m0.36%
$ 11.8m
Clifford Adlerz
Director6.6yrsUS$260.00k0.035%
$ 1.1m
Blair Hendrix
Director3yrssin datossin datos
William Turner
Independent Director8.4yrsUS$285.00k0.049%
$ 1.6m
Patricia Maryland
Independent Director3.3yrsUS$260.00k0.0091%
$ 295.7k
Teresa DeLuca
Independent Director7.7yrsUS$280.00k0.041%
$ 1.3m
John Deane
Independent Director5yrsUS$260.00k0.017%
$ 543.2k
T. O'Reilly
Director6.8yrssin datossin datos
Andrew Kaplan
Director5.8yrssin datossin datos

6.0yrs

Permanencia media

57yo

Promedio de edad

Junta con experiencia: La junta directiva de SGRY se considera experimentada (6 años de antigüedad promedio).